Lv613
2590 积分 2022-05-17 加入
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
16天前
已完结
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
16天前
已完结
TCR-sequencing in cancer and autoimmunity: barcodes and beyond
21天前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
22天前
已完结
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
24天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
26天前
已完结
Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes
27天前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
27天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
27天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
皖公网安备34019202002308
